Tabula Rasa Healthcare Inc. (TRHC) Lifted to “Hold” at Zacks Investment Research

Tabula Rasa Healthcare Inc. (NASDAQ:TRHC) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Tuesday.

According to Zacks, “Tabula Rasa HealthCare, Inc. is a provider of patient-specific, data-driven technology and solutions which enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. The company’s cloud-based software applications including EireneRx and MedWise Advisor which provide solutions to payers, providers and other healthcare organizations. Tabula Rasa HealthCare, Inc. is based in NJ, United States. “

Several other analysts have also issued reports on TRHC. Piper Jaffray Companies began coverage on shares of Tabula Rasa Healthcare in a research report on Monday, October 24th. They issued an “overweight” rating and a $18.00 target price on the stock. Stifel Nicolaus began coverage on shares of Tabula Rasa Healthcare in a research report on Monday, October 24th. They issued a “buy” rating and a $17.00 target price on the stock. Robert W. Baird began coverage on shares of Tabula Rasa Healthcare in a research report on Monday, October 24th. They issued an “outperform” rating and a $17.00 target price on the stock. Finally, Wells Fargo & Company began coverage on shares of Tabula Rasa Healthcare in a research report on Monday, October 24th. They issued an “outperform” rating on the stock. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of $16.75.

Tabula Rasa Healthcare (NASDAQ:TRHC) opened at 16.74 on Tuesday. The stock’s 50 day moving average is $14.73 and its 200 day moving average is $13.45. The stock has a market capitalization of $269.53 million and a price-to-earnings ratio of 64.63. Tabula Rasa Healthcare has a 12-month low of $10.39 and a 12-month high of $16.85.

This story was originally posted by sleekmoney and is owned by of sleekmoney. If you are viewing this story on another website, it was stolen and republished in violation of United States & international copyright & trademark law. The original version of this story can be accessed at http://sleekmoney.com/tabula-rasa-healthcare-inc-trhc-lifted-to-hold-at-zacks-investment-research/1660110.html.

Several institutional investors have recently bought and sold shares of TRHC. DIAM Co. Ltd. acquired a new position in Tabula Rasa Healthcare during the third quarter valued at $136,000. Laurion Capital Management LP acquired a new position in Tabula Rasa Healthcare during the third quarter valued at $430,000. State Street Corp acquired a new position in Tabula Rasa Healthcare during the fourth quarter valued at $611,000. Russell Investments Group Ltd. acquired a new position in Tabula Rasa Healthcare during the fourth quarter valued at $875,000. Finally, Taylor Wealth Management Partners acquired a new position in Tabula Rasa Healthcare during the third quarter valued at $2,458,000. 23.79% of the stock is currently owned by hedge funds and other institutional investors.

Tabula Rasa Healthcare Company Profile

Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.

5 Day Chart for NASDAQ:TRHC

Get a free copy of the Zacks research report on Tabula Rasa Healthcare (TRHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/tabula-rasa-healthcare-inc-trhc-lifted-to-hold-at-zacks-investment-research/1660110.html

Receive News & Ratings for Tabula Rasa Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *